All News Quest Diagnostics Incorporated

Equities

DGX

US74834L1008

Market Closed - Nyse Other stock markets 04:00:02 2024-05-22 pm EDT			5-day change	1st Jan Change
141.9 ^USD	-1.03%		+0.77%	+2.89%

May. 21	Declaration of Voting Results by Quest Diagnostics Incorporated	CI
May. 16	Quest Diagnostics Elects Robert B. Carte to Board of Directors	CI

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Declaration of Voting Results by Quest Diagnostics Incorporated	May. 21	CI
Quest Diagnostics Elects Robert B. Carter, CIO of FedEx Corporation, to Board of Directors	May. 16	PR
Quest Diagnostics Elects Robert B. Carte to Board of Directors	May. 16	CI
Everlasting momentum	May. 16
Argus Research Adjusts Quest Diagnostics Price Target to $215 From $163	May. 16	MT
Baird Adjusts Price Target on Quest Diagnostics to $145 From $144, Keeps Neutral Rating	May. 16	MT
Argus Adjusts Price Target on Quest Diagnostics to $215 From $163, Keeps Buy Rating	May. 16	MT
ANALYST RECOMMENDATIONS : Ecolab, Texas Instruments, Cisco, Britvic, Shopify...	May. 16
Quest Diagnostics Keeps Quarterly Cash Dividend at $0.75 a Share, Payable on July 22 to Shareholders of Record on July 8	May. 15	MT
Quest Diagnostics Declares Quarterly Cash Dividend	May. 15	PR
Quest Diagnostics Incorporated Declares Quarterly Cash Dividend, Payable on July 22, 2024	May. 15	CI
Argus Raises Quest Diagnostics' Price Target to $163 From $155	May. 15	MT
Quest Diagnostics to Speak at the 2024 Leerink Partners Healthcare Crossroads Conference	May. 07	PR
Quest Diagnostics To Acquire PathAI Diagnostics To Accelerate AI and Digital Pathology Adoption in Cancer Diagnosis	May. 06	AQ
Quest Diagnostics Names Murali Balakumar Senior Vice President and Chief Information and Digital Officer	May. 06	PR
Quest Diagnostics Appoints Murali Balakumar as Senior Vice President and Chief Information and Digital Officer	May. 06	CI
Quest Diagnostics to Acquire PathAI Diagnostics Assets in Collaboration Deal	May. 01	MT
Quest Diagnostics Forms Licensing Agreements with PathAI	May. 01	CI
Intelligent Bio Solutions Screening Technologies Poised to Disrupt The Healthcare Sector: INBS, LH, ABT, DGX	May. 01	AQ
Baird Adjusts Quest Diagnostics' Price Target to $144 From $138	Apr. 30	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Quest Diagnostics Incorporated

Equities

DGX

US74834L1008

All News

Filters